Sign up to save your podcasts
Or
Share OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
More shows like Neurology Today in 5
View all
Neurology® Podcast
293 Listeners
NEJM This Week
314 Listeners
Practical Neurology Podcast
48 Listeners
This Week in Cardiology
865 Listeners
JAMA Clinical Reviews
493 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
90 Listeners
BMJ Best Practice Podcast
25 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Neurology Exam Prep Podcast
183 Listeners
The Curious Clinicians
364 Listeners
The Lancet Neurology in conversation with
5 Listeners
Continuum Audio
79 Listeners